Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs

Dig Dis Sci. 2020 Jul;65(7):2044-2045. doi: 10.1007/s10620-020-06108-6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Crohn Disease*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Recurrence
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha